Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Violaine Bourdon

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Genetic Testing and Molecular Biomarkers|March 14, 2014
About sequence quality: impact on clinical applicationsTetsuro Noguchi, Violaine Bourdon, Hagay Sobol
BMC Neurology|January 25, 2011
SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosisGuillaume Rousseau, Tetsuro Noguchi, Violaine Bourdon, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|October 8, 2003
MECP2 mutations or polymorphisms in mentally retarded boys: diagnostic implicationsViolaine Bourdon, Christophe Philippe, Dominique Martin, et al.
Annales De Genetique|June 9, 2004
Chromosome imbalances in oligodendroglial tumors detected by comparative genomic hybridizationViolaine Bourdon, Ghislaine Plessis, Françoise Chapon, et al.
Genetic Testing|August 16, 2002
Spectrum of MECP2 mutations in Rett syndromeThierry Bienvenu, Laurent Villard, Nicolas De Roux, et al.
Human Mutation|February 19, 2009
Quantitative PCR high-resolution melting (qPCR-HRM) curve analysis, a new approach to simultaneously screen point mutations and large rearrangements: application to MLH1 germline mutations in Lynch syndromeEtienne Rouleau, Cédrick Lefol, Violaine Bourdon, et al.
Familial Cancer|September 14, 2016
Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia casesWalid Sabri Hamadou, Sawsen Besbes, Violaine Bourdon, et al.
Journal of Cancer Epidemiology|May 7, 2010
Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation CarriersSylviane Olschwang, Kai Yu, Christine Lasset, et al.
The Prostate|February 18, 2021
Bayesian predictive model to assess BRCA2 mutational status according to clinical history: Early onset, metastatic phenotype or family history of breast/ovary cancerPriscilla Leon, Geraldine Cancel-Tassin, Violaine Bourdon, et al.
Journal of Medical Genetics|August 6, 2010
Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAPArnaud Lagarde, Etienne Rouleau, Anthony Ferrari, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Genetic Testing and Molecular Biomarkers|March 14, 2014
About sequence quality: impact on clinical applicationsTetsuro Noguchi, Violaine Bourdon, Hagay Sobol
BMC Neurology|January 25, 2011
SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosisGuillaume Rousseau, Tetsuro Noguchi, Violaine Bourdon, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|October 8, 2003
MECP2 mutations or polymorphisms in mentally retarded boys: diagnostic implicationsViolaine Bourdon, Christophe Philippe, Dominique Martin, et al.
Annales De Genetique|June 9, 2004
Chromosome imbalances in oligodendroglial tumors detected by comparative genomic hybridizationViolaine Bourdon, Ghislaine Plessis, Françoise Chapon, et al.
Genetic Testing|August 16, 2002
Spectrum of MECP2 mutations in Rett syndromeThierry Bienvenu, Laurent Villard, Nicolas De Roux, et al.
Human Mutation|February 19, 2009
Quantitative PCR high-resolution melting (qPCR-HRM) curve analysis, a new approach to simultaneously screen point mutations and large rearrangements: application to MLH1 germline mutations in Lynch syndromeEtienne Rouleau, Cédrick Lefol, Violaine Bourdon, et al.
Familial Cancer|September 14, 2016
Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia casesWalid Sabri Hamadou, Sawsen Besbes, Violaine Bourdon, et al.
Journal of Cancer Epidemiology|May 7, 2010
Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation CarriersSylviane Olschwang, Kai Yu, Christine Lasset, et al.
The Prostate|February 18, 2021
Bayesian predictive model to assess BRCA2 mutational status according to clinical history: Early onset, metastatic phenotype or family history of breast/ovary cancerPriscilla Leon, Geraldine Cancel-Tassin, Violaine Bourdon, et al.
Journal of Medical Genetics|August 6, 2010
Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAPArnaud Lagarde, Etienne Rouleau, Anthony Ferrari, et al.
Pageof 3